10 results on '"Cherny S. S."'
Search Results
2. Polygenic burden in focal and generalized epilepsies
- Author
-
Leu C., Stevelink R., Smith A. W., Goleva S. B., Kanai M., Ferguson L., Campbell C., Kamatani Y., Okada Y., Sisodiya S. M., Cavalleri G. L., Koeleman B. P. C., Lerche H., Jehi L., Davis L. K., Najm I. M., Palotie A., Daly M. J., Busch R. M., Lal D., Feng Y. -C. A., Howrigan D. P., Abbott L. E., Tashman K., Cerrato F., Churchhouse C., Gupta N., Neale B. M., Berkovic S. F., Goldstein D. B., Lowenstein D. H., Cossette P., Cotsapas C., De Jonghe P., Dixon-Salazar T., Guerrini R., Hakonarson H., Heinzen E. L., Helbig I., Kwan P., Marson A. G., Petrovski S., Kamalakaran S., Stewart R., Weckhuysen S., Depondt C., Dlugos D. J., Scheffer I. E., Striano P., Freyer C., Krause R., May P., McKenna K., Regan B. M., Bellows S. T., Bennett C. A., Johns E. M. C., Macdonald A., Shilling H., Burgess R., Weckhuysen D., Bahlo M., O'Brien T. J., Todaro M., Stamberger H., Andrade D. M., Sadoway T. R., Mo K., Krestel H., Gallati S., Papacostas S. S., Kousiappa I., Tanteles G. A., Sterbova K., Vlckova M., Sedlackova L., Lassuthova P., Klein K. M., Rosenow F., Reif P. S., Knake S., Kunz W. S., Zsurka G., Elger C. E., Bauer J., Rademacher M., Pendziwiat M., Muhle H., Rademacher A., Van Baalen A., Von Spiczak S., Stephani U., Afawi Z., Korczyn A. D., Kanaan M., Canavati C., Kurlemann G., Muller-Schluter K., Kluger G., Hausler M., Blatt I., Lemke J. R., Krey I., Weber Y. G., Wolking S., Becker F., Hengsbach C., Rau S., Maisch A. F., Steinhoff B. J., Schulze-Bonhage A., Schubert-Bast S., Schreiber H., Borggrafe I., Schankin C. J., Mayer T., Korinthenberg R., Brockmann K., Dennig D., Madeleyn R., Kalviainen R., Auvinen P., Saarela A., Linnankivi T., Lehesjoki A. -E., Rees M. I., Chung S. -K., Pickrell W. O., Powell R., Schneider N., Balestrini S., Zagaglia S., Braatz V., Johnson M. R., Auce P., Sills G. J., Baum L. W., Sham P. C., Cherny S. S., Lui C. H. T., Barisic N., Delanty N., Doherty C. P., Shukralla A., McCormack M., El-Naggar H., Canafoglia L., Franceschetti S., Castellotti B., Granata T., Zara F., Iacomino M., Madia F., Vari M. S., Mancardi M. M., Salpietro V., Bisulli F., Tinuper P., Licchetta L., Pippucci T., Stipa C., Muccioli L., Minardi R., Gambardella A., Labate A., Annesi G., Manna L., Gagliardi M., Parrini E., Mei D., Vetro A., Bianchini C., Montomoli M., Doccini V., Marini C., Suzuki T., Inoue Y., Yamakawa K., Birute T., Ruta M., Algirdas U., Ruta P., Jurgita G., Ruta S., Sadleir L. G., King C., Mountier E., Caglayan S. H., Arslan M., Yapici Z., Yis U., Topaloglu P., Kara B., Turkdogan D., Gundogdu-Eken A., Bebek N., Ugur-Iseri S., Baykan B., Salman B., Haryanyan G., Yucesan E., Kesim Y., Ozkara C., Sheidley B. R., Shain C., Poduri A., Buono R. J., Ferraro T. N., Sperling M. R., Lo W., Privitera M., French J. A., Schachter S., Kuzniecky R. I., Devinsky O., Hegde M., Khankhanian P., Helbig K. L., Ellis C. A., Spalletta G., Piras F., Gili T., Ciullo V., Leu C., Stevelink R., Smith A.W., Goleva S.B., Kanai M., Ferguson L., Campbell C., Kamatani Y., Okada Y., Sisodiya S.M., Cavalleri G.L., Koeleman B.P.C., Lerche H., Jehi L., Davis L.K., Najm I.M., Palotie A., Daly M.J., Busch R.M., Lal D., Feng Y.-C.A., Howrigan D.P., Abbott L.E., Tashman K., Cerrato F., Churchhouse C., Gupta N., Neale B.M., Berkovic S.F., Goldstein D.B., Lowenstein D.H., Cossette P., Cotsapas C., De Jonghe P., Dixon-Salazar T., Guerrini R., Hakonarson H., Heinzen E.L., Helbig I., Kwan P., Marson A.G., Petrovski S., Kamalakaran S., Stewart R., Weckhuysen S., Depondt C., Dlugos D.J., Scheffer I.E., Striano P., Freyer C., Krause R., May P., McKenna K., Regan B.M., Bellows S.T., Bennett C.A., Johns E.M.C., Macdonald A., Shilling H., Burgess R., Weckhuysen D., Bahlo M., O'Brien T.J., Todaro M., Stamberger H., Andrade D.M., Sadoway T.R., Mo K., Krestel H., Gallati S., Papacostas S.S., Kousiappa I., Tanteles G.A., Sterbova K., Vlckova M., Sedlackova L., Lassuthova P., Klein K.M., Rosenow F., Reif P.S., Knake S., Kunz W.S., Zsurka G., Elger C.E., Bauer J., Rademacher M., Pendziwiat M., Muhle H., Rademacher A., Van Baalen A., Von Spiczak S., Stephani U., Afawi Z., Korczyn A.D., Kanaan M., Canavati C., Kurlemann G., Muller-Schluter K., Kluger G., Hausler M., Blatt I., Lemke J.R., Krey I., Weber Y.G., Wolking S., Becker F., Hengsbach C., Rau S., Maisch A.F., Steinhoff B.J., Schulze-Bonhage A., Schubert-Bast S., Schreiber H., Borggrafe I., Schankin C.J., Mayer T., Korinthenberg R., Brockmann K., Dennig D., Madeleyn R., Kalviainen R., Auvinen P., Saarela A., Linnankivi T., Lehesjoki A.-E., Rees M.I., Chung S.-K., Pickrell W.O., Powell R., Schneider N., Balestrini S., Zagaglia S., Braatz V., Johnson M.R., Auce P., Sills G.J., Baum L.W., Sham P.C., Cherny S.S., Lui C.H.T., Barisic N., Delanty N., Doherty C.P., Shukralla A., McCormack M., El-Naggar H., Canafoglia L., Franceschetti S., Castellotti B., Granata T., Zara F., Iacomino M., Madia F., Vari M.S., Mancardi M.M., Salpietro V., Bisulli F., Tinuper P., Licchetta L., Pippucci T., Stipa C., Muccioli L., Minardi R., Gambardella A., Labate A., Annesi G., Manna L., Gagliardi M., Parrini E., Mei D., Vetro A., Bianchini C., Montomoli M., Doccini V., Marini C., Suzuki T., Inoue Y., Yamakawa K., Birute T., Ruta M., Algirdas U., Ruta P., Jurgita G., Ruta S., Sadleir L.G., King C., Mountier E., Caglayan S.H., Arslan M., Yapici Z., Yis U., Topaloglu P., Kara B., Turkdogan D., Gundogdu-Eken A., Bebek N., Ugur-Iseri S., Baykan B., Salman B., Haryanyan G., Yucesan E., Kesim Y., Ozkara C., Sheidley B.R., Shain C., Poduri A., Buono R.J., Ferraro T.N., Sperling M.R., Lo W., Privitera M., French J.A., Schachter S., Kuzniecky R.I., Devinsky O., Hegde M., Khankhanian P., Helbig K.L., Ellis C.A., Spalletta G., Piras F., Gili T., Ciullo V., Commission of the European Communities, Medical Research Council (MRC), Tumienė, Birutė, Mameniškienė, Rūta, Utkus, Algirdas, Praninskienė, Rūta, Grikinienė, Jurgita, Samaitienė-Aleknienė, Rūta, Centre of Excellence in Complex Disease Genetics, Aarno Palotie / Principal Investigator, Institute for Molecular Medicine Finland, Genomics of Neurological and Neuropsychiatric Disorders, University of Helsinki, Helsinki Institute of Life Science HiLIFE, and Department of Medical and Clinical Genetics
- Subjects
0301 basic medicine ,Male ,Multifactorial Inheritance ,Epi25 Consortium ,Databases, Factual ,FEATURES ,Genome-wide association study ,Epilepsies ,3124 Neurology and psychiatry ,Cohort Studies ,Epilepsy ,0302 clinical medicine ,Cost of Illness ,1ST SEIZURE ,HISTORY ,genetics ,POPULATION ,11 Medical and Health Sciences ,education.field_of_study ,medicine.diagnostic_test ,SCORES ,Single Nucleotide ,Biobank ,3. Good health ,17 Psychology and Cognitive Sciences ,Genetic generalized epilepsy ,Epilepsy, Generalized ,Female ,Partial ,Cohort study ,Human ,medicine.medical_specialty ,Population ,European Continental Ancestry Group ,Clinical Neurology ,BIOBANK ,Polymorphism, Single Nucleotide ,epilepsy ,genetic generalized epilepsy ,common variant risk ,Databases ,03 medical and health sciences ,Genetic ,Internal medicine ,medicine ,Journal Article ,Genetics ,Humans ,Genetic Predisposition to Disease ,Polymorphism ,GENOME-WIDE ASSOCIATION ,Generalized epilepsy ,education ,SEIZURE RECURRENCE ,Factual ,METAANALYSIS ,Genetic testing ,Neurology & Neurosurgery ,RISK PREDICTION ,Generalized ,business.industry ,3112 Neurosciences ,Common variant risk ,Genetic Variation ,Original Articles ,medicine.disease ,Comorbidity ,Cost of Illne ,Epilepsies, Partial ,Genome-Wide Association Study ,030104 developmental biology ,Neurology (clinical) ,Cohort Studie ,business ,030217 neurology & neurosurgery - Abstract
See Hansen and Møller (doi:10.1093/brain/awz318) for a scientific commentary on this article. Using polygenic risk scores from a genome-wide association study in generalized and focal epilepsy, Leu et al. reveal a significantly higher genetic burden for epilepsy in multiple cohorts of people with epilepsy compared to population controls. Quantification of common variant burden may be valuable for epilepsy prognosis and treatment., Rare genetic variants can cause epilepsy, and genetic testing has been widely adopted for severe, paediatric-onset epilepsies. The phenotypic consequences of common genetic risk burden for epilepsies and their potential future clinical applications have not yet been determined. Using polygenic risk scores (PRS) from a European-ancestry genome-wide association study in generalized and focal epilepsy, we quantified common genetic burden in patients with generalized epilepsy (GE-PRS) or focal epilepsy (FE-PRS) from two independent non-Finnish European cohorts (Epi25 Consortium, n = 5705; Cleveland Clinic Epilepsy Center, n = 620; both compared to 20 435 controls). One Finnish-ancestry population isolate (Finnish-ancestry Epi25, n = 449; compared to 1559 controls), two European-ancestry biobanks (UK Biobank, n = 383 656; Vanderbilt biorepository, n = 49 494), and one Japanese-ancestry biobank (BioBank Japan, n = 168 680) were used for additional replications. Across 8386 patients with epilepsy and 622 212 population controls, we found and replicated significantly higher GE-PRS in patients with generalized epilepsy of European-ancestry compared to patients with focal epilepsy (Epi25: P = 1.64×10−15; Cleveland: P = 2.85×10−4; Finnish-ancestry Epi25: P = 1.80×10−4) or population controls (Epi25: P = 2.35×10−70; Cleveland: P = 1.43×10−7; Finnish-ancestry Epi25: P = 3.11×10−4; UK Biobank and Vanderbilt biorepository meta-analysis: P = 7.99×10−4). FE-PRS were significantly higher in patients with focal epilepsy compared to controls in the non-Finnish, non-biobank cohorts (Epi25: P = 5.74×10−19; Cleveland: P = 1.69×10−6). European ancestry-derived PRS did not predict generalized epilepsy or focal epilepsy in Japanese-ancestry individuals. Finally, we observed a significant 4.6-fold and a 4.5-fold enrichment of patients with generalized epilepsy compared to controls in the top 0.5% highest GE-PRS of the two non-Finnish European cohorts (Epi25: P = 2.60×10−15; Cleveland: P = 1.39×10−2). We conclude that common variant risk associated with epilepsy is significantly enriched in multiple cohorts of patients with epilepsy compared to controls—in particular for generalized epilepsy. As sample sizes and PRS accuracy continue to increase with further common variant discovery, PRS could complement established clinical biomarkers and augment genetic testing for patient classification, comorbidity research, and potentially targeted treatment.
- Published
- 2019
- Full Text
- View/download PDF
3. Erratum: Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort
- Author
-
Toulopoulou, T, van Haren, N, Zhang, X, Sham, P C, Cherny, S S, Campbell, D D, Picchioni, M, Murray, R, Boomsma, D I, Hulshoff Pol, Hilleke E, Brouwer, R, Schnack, H, Fañanás, L, Sauer, H, Nenadic, I, Weisbrod, M, Cannon, T D, and Kahn, R S
- Published
- 2015
- Full Text
- View/download PDF
4. SNP-based HLA allele tagging, imputation and association with antiepileptic drug-induced cutaneous reactions in Hong Kong Han Chinese
- Author
-
Gui, H, primary, Kwok, M, additional, Baum, L, additional, Sham, P C, additional, Kwan, P, additional, and Cherny, S S, additional
- Published
- 2017
- Full Text
- View/download PDF
5. Erratum : Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort (Molecular Psychiatry (2015) 20, 1386-1396; DOI:10.1038/mp.2014.152)
- Author
-
Toulopoulou, T., Van Haren, N., Zhang, X., Sham, P. C., Cherny, S. S., Campbell, D. D., Picchioni, M., Murray, R., Boomsma, D. I., Pol, H.H., Brouwer, R., Schnack, H., Fañanás, L., Sauer, H., Nenadic, I., Weisbrod, M., Cannon, T. D., Kahn, R. S., Toulopoulou, T., Van Haren, N., Zhang, X., Sham, P. C., Cherny, S. S., Campbell, D. D., Picchioni, M., Murray, R., Boomsma, D. I., Pol, H.H., Brouwer, R., Schnack, H., Fañanás, L., Sauer, H., Nenadic, I., Weisbrod, M., Cannon, T. D., and Kahn, R. S.
- Published
- 2015
6. Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort
- Author
-
Toulopoulou, T., van Haren, N., Zhang, X., Sham, P. C., Cherny, S. S., Campbell, D. D., Picchioni, M., Murray, R., Boomsma, D. I., Pol, H. H., Brouwer, R., Schnack, H., Fananas, L., Sauer, H., Nenadic, I., Weisbrod, M., Cannon, T. D., Kahn, R. S., Toulopoulou, T., van Haren, N., Zhang, X., Sham, P. C., Cherny, S. S., Campbell, D. D., Picchioni, M., Murray, R., Boomsma, D. I., Pol, H. H., Brouwer, R., Schnack, H., Fananas, L., Sauer, H., Nenadic, I., Weisbrod, M., Cannon, T. D., and Kahn, R. S.
- Published
- 2015
7. Erratum: Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort (Molecular Psychiatry (2015) 20, 1386-1396; DOI:10.1038/mp.2014.152)
- Author
-
Onderzoeksgroep 4, Brain, Onderzoeksgroep 1, Ontwikkelingsstoornissen Zorg, Onderzoek, Toulopoulou, T., Van Haren, N., Zhang, X., Sham, P. C., Cherny, S. S., Campbell, D. D., Picchioni, M., Murray, R., Boomsma, D. I., Pol, H.H., Brouwer, R., Schnack, H., Fañanás, L., Sauer, H., Nenadic, I., Weisbrod, M., Cannon, T. D., Kahn, R. S., Onderzoeksgroep 4, Brain, Onderzoeksgroep 1, Ontwikkelingsstoornissen Zorg, Onderzoek, Toulopoulou, T., Van Haren, N., Zhang, X., Sham, P. C., Cherny, S. S., Campbell, D. D., Picchioni, M., Murray, R., Boomsma, D. I., Pol, H.H., Brouwer, R., Schnack, H., Fañanás, L., Sauer, H., Nenadic, I., Weisbrod, M., Cannon, T. D., and Kahn, R. S.
- Published
- 2015
8. Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort
- Author
-
Onderzoeksgroep 4, Brain, Ontwikkelingsstoornissen Zorg, Onderzoek, Toulopoulou, T., van Haren, N., Zhang, X., Sham, P. C., Cherny, S. S., Campbell, D. D., Picchioni, M., Murray, R., Boomsma, D. I., Pol, H. H., Brouwer, R., Schnack, H., Fananas, L., Sauer, H., Nenadic, I., Weisbrod, M., Cannon, T. D., Kahn, R. S., Onderzoeksgroep 4, Brain, Ontwikkelingsstoornissen Zorg, Onderzoek, Toulopoulou, T., van Haren, N., Zhang, X., Sham, P. C., Cherny, S. S., Campbell, D. D., Picchioni, M., Murray, R., Boomsma, D. I., Pol, H. H., Brouwer, R., Schnack, H., Fananas, L., Sauer, H., Nenadic, I., Weisbrod, M., Cannon, T. D., and Kahn, R. S.
- Published
- 2015
9. Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort
- Author
-
Toulopoulou, T, primary, van Haren, N, additional, Zhang, X, additional, Sham, P C, additional, Cherny, S S, additional, Campbell, D D, additional, Picchioni, M, additional, Murray, R, additional, Boomsma, D I, additional, Pol, H H, additional, Brouwer, R, additional, Schnack, H, additional, Fañanás, L, additional, Sauer, H, additional, Nenadic, I, additional, Weisbrod, M, additional, Cannon, T D, additional, and Kahn, R S, additional
- Published
- 2014
- Full Text
- View/download PDF
10. SNP-based HLA allele tagging, imputation and association with antiepileptic drug-induced cutaneous reactions in Hong Kong Han Chinese
- Author
-
Gui, H, Kwok, M, Baum, L, Sham, P C, Kwan, P, and Cherny, S S
- Abstract
Human leukocyte antigen (HLA) genes control the regulation of the human immune system and are involved in immune-related diseases. Population surveys on relationships between single nucleotide polymorphisms (SNP) and HLA alleles are essential to conduct genetic association between HLA variants and diseases. Samples were obtained from our in-house database for epilepsy genetics and pharmacogenetics research. Using 184 epilepsy patients with both genome-wide SNP array and HLA-A/B candidate gene sequencing data, we sought tagging SNPs that completely represent sixHLA risk alleles; in addition, a Hong Kong population-specific reference panel was constructed for SNP-based HLA imputation. The performance of our new panel was compared to a recent Han Chinese panel. Finally, genetic associations of HLA variants with mild skin rash were performed on the combined sample of 408 patients. Common SNPs rs2571375 and rs144295468 were found to successfully tag HLA risk alleles A*31:01 and B*13:01, respectively. HLA-B*15:02 can be predicted by rs144012689 with >95% sensitivity and specificity. The imputation reference panel for the Hong Kong population had comparable performance to the Han Chinese panel due to the large sample size for common HLA alleles, though it retained discordance for imputing rare alleles. No significant genetic associations were found between HLA genetic variants and mild skin rash induced by aromatic antiepileptic drugs. This study provides new information on the genetic structure of HLA regions in the Hong Kong population by identifying tagging SNPs and serving as a reference panel. Moreover, our comprehensive genetic analyses revealed no significant association between HLA alleles and mild skin rash in Hong Kong Han Chinese.
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.